NCNA - NuCana plc - ADR
IEX Last Trade
3.49
-4.240 -121.490%
Share volume: 438,395
Last Updated: Fri 30 Aug 2024 08:48:11 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.73
-4.24
-54.85%
Summary score
22%
Profitability
18%
Dept financing
2%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.41%
Return on assets
-8.15%
Return on sales
0%
Return on invested capital
-618.41%
Total debt ratio
7.29%
Debt ratio change over timeo
-0.97%
Current Ratio
15.69%
Quick Ratio
0%
Cash Position Ratio
11.78%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.68%
Return on assets
-10.29%
Return on sales
0%
Return on invested capital
582.31%
Total debt ratio
9.46%
Debt ratio change over timeo
-0.98%
Current Ratio
10.69%
Quick Ratio
0%
Cash Position Ratio
8.56%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-10.66%
Return on assets
-11.74%
Return on sales
0%
Return on invested capital
594.08%
Total debt ratio
10.88%
Debt ratio change over time
-0.98%
Current Ratio
8.99%
Quick Ratio
0%
Cash Position Ratio
7.34%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.08%
Return on assets
-102.71%
Return on sales
0%
Return on invested capital
29.07%
Total debt ratio
-97.35%
Debt ratio change over time
-0.97%
Current Ratio
4.21%
Quick Ratio
0%
Cash Position Ratio
3.59%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NCNA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -6.41% | -3.05% | 11.55% | 6.27% |
| Return on assets | -8.15% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -618.41% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 7.29% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.97% | 6.09% | 6.03% | 1.53% |
| Dept financing | 2% | 50% | 43% | 14% |
| Current Ratio | 10.69% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.56% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 14% | 32% | 31% |
| Short-term ratios | NCNA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.68% | -25.62% | 17.94% | 7.14% |
| Return on assets | -10.29% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 582.31% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 38% | 70% | 58% |
| Total debt ratio | 9.46% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.98% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 10.69% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.56% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 26% | 22% | 38% |